Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA's Spielberg To Focus On Cross-Center Collaboration, Hamburg Says

Executive Summary

Incoming FDA Deputy Commissioner for Medical Products and Tobacco Stephen Spielberg will be given two clear mandates when he arrives at the agency: coordination and integration.

You may also be interested in...



Finally … Rachel Sherman Takes Califf's Old FDA Job

After months of speculation, FDA veteran Rachel Sherman becomes deputy commissioner for medical products and tobacco.

Oral History Of Drug Development: FDA’s Califf Wants Woodcock, Temple To Share Their Stories

In an interview with “The Pink Sheet,” new deputy commissioner for medical products says FDA needs better ways of helping stakeholders, public understand agency thinking.

FDA Ready To Hire New Deputy Commissioner For Medical Products And Tobacco

The winning candidate would be the third to hold the position in two years; job notice will be corrected, though – top secret clearance is not required.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS053647

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel